5 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Not yet recruiting 1 |
Follow Nicole Hamblett: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rethinking Early Airway Clearence Therapies As-needed hypertonic saline (HS), Twice daily hypertonic saline (HS), As-needed dornase alfa (DA) - Cystic Fibrosis (CF) | Not applicable | Not yet recruiting | Nicole Hamblett | 405 | 2026-12-15 | 2026-11-19 |
| A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators Cystic Fibrosis | Recruiting | Nicole Hamblett | 400 | 2024-09-18 | 2026-11-19 | |
| The PROMISE Pediatric Study 6 to 11 Years Old Cystic Fibrosis, Cystic Fibrosis in Children | Completed | Nicole Hamblett | 125 | 2021-06-11 | 2026-04-27 | |
| Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study Discontinuation of hypertonic saline (HS), Continuation of hypertonic saline (HS) - Cystic Fibrosis | Not applicable | Completed | Nicole Hamblett | 370 | 2020-08-25 | 2024-10-01 |
| Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study Discontinuation of dornase alfa (Dnase), Continuation of dornase alfa (Dnase) - Cystic Fibrosis | Not applicable | Completed | Nicole Hamblett | 477 | 2020-08-25 | 2024-11-26 |
| Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy Cystic Fibrosis | Completed | Nicole Hamblett | 987 | 2020-08-25 | 2024-12-04 | |
| A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function Cystic Fibrosis | Completed | Nicole Hamblett | 490 | 2019-10-22 | 2025-01-28 | |
| CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes Cystic Fibrosis | Active not recruiting | Nicole Hamblett | 5000 | 2018-01-15 | 2025-10-10 |
Cystic Fibrosis (8)
United States (8) · Canada (1)
Nicole Mayer-Hamblett, PhD (5) · Alex Gifford, MD, FCCP (3) · David Nichols, MD (2) · Steven Rowe, MD (2) · Deepika Polineni, MD, MPH (1) · Edith Zemanick, MD (1) · Felix Ratjen, MD (1) · Felix Ratjen, MD, PhD (1) · Jonathan Rayment, MDCM, MSc, FRCPC (1) · Margaret Rosenfeld, MD, MPH (1) · Michael Konstan, MD (1) · Scott Donaldson, MD (1)
PMID 33465316, PMID 33735508, PMID 34784492, PMID 36280527, PMID 36343646, PMID 36976651, PMID 37100705, PMID 38153868, PMID 40540670, PMID 40961158